Stephen V Liu/X
Feb 9, 2025, 04:27
Stephen V Liu: How do we overcome resistance to osimertinib in EGFR mutant NSCLC?
Stephen V Liu, Associate Professor of Medicine at Georgetown University, Director of Thoracic Oncology and Head of Developmental Therapeutics at the Georgetown Lombardi Comprehensive Cancer Center, shared a post on X:
“How do we overcome resistance to osimertinib in EGFR mutant NSCLC?
That’s the topic of this IASLC podcast episode with Drs. Rachel E. Sanborn and Yasushi Goto. New episode of Lung Cancer Considered next Tuesday!”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Sep 7, 2025, 16:47
Sep 7, 2025, 16:30
Sep 7, 2025, 16:25